Peyre, Marion
Sicre de Fontbrune, Flore http://orcid.org/0000-0003-2000-1556
Berceanu, Ana
Benjemia, Lise
Castelle, Martin
D’Aveni, Maud http://orcid.org/0000-0002-5909-2742
Marçais, Ambroise http://orcid.org/0000-0002-6844-7920
Kaphan, Eleonore
Bulabois, Claude-Eric
Sirvent, Anne
Rohrlich, Pierre-Simon http://orcid.org/0000-0001-8801-4164
Coiteux, Valerie
Chantepie, Sylvain
Nguyen-Quoc, Stéphanie
Peffault de Latour, Régis
Coppo, Paul
Article History
Received: 25 August 2023
Revised: 14 February 2024
Accepted: 3 April 2024
First Online: 11 April 2024
Competing interests
: PC received research grants and is a member of advisory board of Sanofi, Alexion, Takeda, Janssen. FSDF and RPL received honoraria and research support (to Saint-Louis Hospital, Paris) from Alexion, AstraZeneca Rare Disease, Samsung and Sobi.